These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24598459)

  • 1. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.
    Kiertiburanakul S; Boettiger D; Lee MP; Omar SF; Tanuma J; Ng OT; Durier N; Phanuphak P; Ditangco R; Chaiwarith R; Kantipong P; Lee CK; Mustafa M; Saphonn V; Ratanasuwan W; Merati TP; Kumarasamy N; Wong WW; Zhang F; Pham TT; Pujari S; Choi JY; Yunihastuti E; Sungkanuparph S; ;
    J Int AIDS Soc; 2014; 17(1):18804. PubMed ID: 24598459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in CD4 cell count response to first-line antiretroviral treatment in HIV-positive patients from Asia, 2003-2013: TREAT Asia HIV Observational Database Low Intensity Transfer.
    De La Mata NL; Ly PS; Ng OT; Nguyen KV; Merati TP; Pham TT; Lee MP; Choi JY; Sohn AH; Law MG; Kumarasamy N
    Int J STD AIDS; 2017 Nov; 28(13):1282-1291. PubMed ID: 28632481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
    Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
    Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.
    Sun J; Liu L; Shen J; Chen P; Lu H
    BMC Infect Dis; 2017 Apr; 17(1):285. PubMed ID: 28420350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care.
    Cescon A; Patterson S; Davey C; Ding E; Raboud JM; Chan K; Loutfy MR; Cooper C; Burchell AN; Palmer AK; Tsoukas C; Machouf N; Klein MB; Rourke SB; Rachlis A; Hogg RS; Montaner JS;
    J Int AIDS Soc; 2015; 18(1):20024. PubMed ID: 26443752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
    O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
    Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV treatment outcomes among people who acquired HIV via injecting drug use in the Asia-Pacific region: a longitudinal cohort study.
    Han WM; Jiamsakul A; Salleh NAM; Choi JY; Huy BV; Yunihastuti E; Do CD; Merati TP; Gani YM; Kiertiburanakul S; Zhang F; Chan YJ; Lee MP; Chaiwarith R; Ng OT; Khusuwan S; Ditangco R; Kumarasamy N; Sangle S; Ross J; Avihingsanon A;
    J Int AIDS Soc; 2021 May; 24(5):e25736. PubMed ID: 34021711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with delayed and late ART initiation among people living with HIV in BC: results from the engage study.
    Kesselring S; Osborne C; Bever A; Salters K; Cui Z; Chia J; Moore DM; Parashar S; Kaida A; Samji H; Duddy J; Gabler K; Howard T; Nash D; McCandless LC; Patterson TL; Corneil T; Montaner JSG; Hogg RS
    AIDS Care; 2019 Jul; 31(7):885-892. PubMed ID: 30466303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic and clinical factors correlated with clinical outcomes among people with HIV treated by antiretroviral therapy: a retrospective cohort study.
    Li Y; Liu H; Zhang S; Zhang Y; Wang H; Zhang H; Li X
    BMC Infect Dis; 2024 May; 24(1):514. PubMed ID: 38778273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013.
    Nash D; Tymejczyk O; Gadisa T; Kulkarni SG; Hoffman S; Yigzaw M; Elul B; Remien RH; Lahuerta M; Daba S; El Sadr W; Melaku Z
    J Int AIDS Soc; 2016; 19(1):20637. PubMed ID: 27113335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort Study.
    Chammartin F; Lodi S; Logan R; Ryom L; Mocroft A; Kirk O; d'Arminio Monforte A; Reiss P; Phillips A; El-Sadr W; Hatleberg CI; Pradier C; Bonnet F; Law M; De Wit S; Sabin C; Lundgren JD; Bucher HC;
    Ann Intern Med; 2021 Jun; 174(6):768-776. PubMed ID: 33721519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival in HIV treatment programmes in Asia.
    De La Mata NL; Kumarasamy N; Khol V; Ng OT; Van Nguyen K; Merati TP; Pham TT; Lee MP; Durier N; Law M
    Antivir Ther; 2016; 21(6):517-527. PubMed ID: 26961354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
    AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
    Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
    PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific.
    Rupasinghe D; Kiertiburanakul S; Kamarulzaman A; Zhang F; Kumarasamy N; Chaiwarith R; Merati TP; Do CD; Khusuwan S; Avihingsanon A; Lee MP; Ly PS; Yunihastuti E; Nguyen KV; Ditangco R; Chan YJ; Pujari S; Ng OT; Choi JY; Sim B; Tanuma J; Sangle S; Ross J; Law M
    HIV Med; 2020 Jul; 21(6):397-402. PubMed ID: 31852025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015.
    Mehraj V; Cox J; Lebouché B; Costiniuk C; Cao W; Li T; Ponte R; Thomas R; Szabo J; Baril JG; Trottier B; Côté P; LeBlanc R; Bruneau J; Tremblay C; Routy JP;
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29412520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town.
    Kaplan R; Hermans S; Caldwell J; Jennings K; Bekker LG; Wood R
    BMC Infect Dis; 2018 Jul; 18(1):356. PubMed ID: 30064368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with late antiretroviral therapy initiation among adults in Mozambique.
    Lahuerta M; Lima J; Nuwagaba-Biribonwoha H; Okamura M; Alvim MF; Fernandes R; Assan A; Hoos D; Elul B; El-Sadr WM; Nash D
    PLoS One; 2012; 7(5):e37125. PubMed ID: 22615917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
    Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
    J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.